8.09 USD
↗ 0.12 (1.51%)AT CLOSE (11:59 AM EDT)
Aligos Therapeutics, Inc. Common Stock
ALGSNASDAQ • USD
8.24
↘ 0.03 (0.37%)
POST MARKET (AS OF 04:14 PM EDT)
Post Market
AS OF 04:14 PM EDT
8.24
↘ 0.03 (0.37%)
Market: OPEN
Open?$7.94
High?$8.64
Low?$7.90
Prev. Close?$7.97
Volume?58.5K
Avg. Volume?40.0K
VWAP?$8.30
Rel. Volume?1.46x
Bid / Ask
Bid?$7.90 × 100
Ask?$8.21 × 200
Spread?$0.31
Midpoint?$8.06
Valuation & Ratios
Market Cap?49.3M
Shares Out?5.4M
Float?4.6M
Float %?75.5%
P/E Ratio?N/A
P/B Ratio?0.92
EPS?-$3.91
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.90Strong
Quick Ratio?3.90Strong
Cash Ratio?0.86Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?0.92CHEAP▾
P/S?22.56HIGH▾
P/FCF?N/A▾
EV/EBITDA?-0.4CHEAP▾
EV/Sales?14.28HIGH▾
Returns & Efficiency
ROE?-45.2%WEAK▾
ROA?-27.3%WEAK▾
Cash Flow & Enterprise
FCF?$-82940000
Enterprise Value?$31.2M
Related Companies
Loading...
News
Profile
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
Employees
82
Market Cap
49.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-10-16
Address
ONE CORPORATE DR., 2ND FLOOR
SOUTH SAN FRANCISCO, CA 94080
Phone: (800) 466-6059
SOUTH SAN FRANCISCO, CA 94080
Phone: (800) 466-6059